Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Tata India Pharma & Healthcare Fund · Direct ✕ICICI Prudential Business Cycle Fund · Direct ✕

Growth of ₹10,000

Basics

Tata India Pharma & Healthcare FundICICI Prudential Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseTataICICI Pru
AUM₹1,534 Cr₹15,842 Cr
NAV₹38.9215₹27.8400
NAV date20 Nov 202620 Nov 2026
History—5.8 years
Expense ratio1.1%1.0%
StarsNot rated★★★★★
Growth Score—79.20

AUM: AMFI's average assets under management for July - September 2026, in ₹ crore, for the whole fund (Direct and Regular, Growth and IDCW added up). The same source and period for every fund, so the figures compare.

Returns

Tata India Pharma & Healthcare FundICICI Prudential Business Cycle Fund
1 month—+11.58%
3 months—+4.70%
6 months—+8.33%
YTD—+2.02%
1 year—+1.64%
3 years (CAGR)—+16.92%
5 years (CAGR)—+16.09%
10 years (CAGR)——
Since launch—+19.15%

Risk

Tata India Pharma & Healthcare FundICICI Prudential Business Cycle Fund
Volatility—15.4%
Downside volatility—9.7%
Sharpe—0.68
Sortino—1.07
Calmar—1.18
Return / risk—1.10
Deepest fall—−14.39%
Days to recover—101
Below its high—0.00%

Against benchmark

Tata India Pharma & Healthcare FundICICI Prudential Business Cycle Fund
Alpha—+4.27%
Beta—0.92
R²—92.0%
Up capture—103.3%
Down capture—80.8%
Tracking error—4.6%
Information ratio—0.83
Treynor—0.10

Consistency

Tata India Pharma & Healthcare FundICICI Prudential Business Cycle Fund
Best 1-year—+57.85%
Middle 1-year—+14.06%
Worst 1-year—−9.72%
1-year periods with a loss—4.1%
Middle 3-year—+23.35%
Positive months—61.1%
Best day—+4.49%
Worst day—−5.43%
Worst 5% day—−1.26%
Positive days—54.8%
NAVs a year—247

SIP of ₹10,000 a month

Tata India Pharma & Healthcare FundICICI Prudential Business Cycle Fund
5-year XIRR—+15.82%
5-year value—₹8,98,335
3-year XIRR—+10.13%
1-year XIRR—+10.49%

Holdings overlap i

Tata India Pharma & Healthcare FundICICI Prudential Business Cycle Fund
Tata India Pharma & Healthcare Fund
Direct · filing Oct 2026
—0%
ICICI Prudential Business Cycle Fund
Direct · filing Oct 2026
0%—

Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.

Tata India Pharma & Healthcare Fund and ICICI Prudential Business Cycle Fund

Overlap
0.5%
smaller weight of each shared stock, added up
Stocks in common
1
of 39 and 74
Weight in common
0% · 0%
of each fund's money
Filings compared
Oct 2026 · Oct 2026
same month
Common stockTata India Pharma & Healthcare FundICICI Prudential Business Cycle FundCounts toward overlap
PI Industries Limited0.46%0.50%0.46%
1 stocks0.5%0.5%0.5%

Only in Tata India Pharma & Healthcare Fund (38)

Sun Pharmaceutical Industries Limited7.89%
Abbott India Limited5.66%
Divi's Laboratories Limited5.41%
Healthcare Global Enterprises Limited5.25%
Dr. Reddy's Laboratories Limited5.14%
Torrent Pharmaceuticals Limited4.73%
Apollo Hospitals Enterprise Limited4.55%
Max Healthcare Institute Limited4.28%
Rainbow Childrens Medicare Limited4.02%
Sai Life Sciences Limited3.22%
Syngene International Limited3.17%
Procter & Gamble Health Limited3.15%
Lupin Limited3.13%
Cipla Limited3.08%
Anthem Biosciences Limited2.99%
Natco Pharma Limited2.86%
FDC Limited2.69%
Bayer Cropscience Limited2.68%
Acutaas Chemicals Limited2.40%
Pfizer Limited2.40%
Aster DM Quality Care Limited2.33%
Biocon Limited2.23%
Navin Fluorine International Limited2.15%
Sanofi Consumer Healthcare India Limited1.99%
Ajanta Pharma Limited1.59%

and 13 smaller holdings (10.3% of the fund).

Only in ICICI Prudential Business Cycle Fund (73)

HDFC Bank Limited9.53%
ICICI Bank Limited7.22%
Reliance Industries Limited5.31%
Kotak Mahindra Bank Limited3.76%
Mahindra & Mahindra Limited3.73%
Maruti Suzuki India Limited3.41%
Bharti Airtel Limited3.40%
DLF Limited3.07%
HDFC Life Insurance Company Limited3.02%
Larsen & Toubro Limited2.93%
UltraTech Cement Limited2.84%
Xtrackers Harvest CSI 300 China A-Shares ETF2.75%
Hero MotoCorp Limited2.45%
NTPC Limited2.33%
InterGlobe Aviation Limited2.23%
Prestige Estates Projects Limited1.94%
Asian Paints Limited1.78%
SBI Life Insurance Company Limited1.67%
Axis Bank Limited1.46%
Trent Limited1.42%
Info Edge (India) Limited1.40%
ICICI Lombard General Insurance Company Limited1.34%
Hyundai Motor India Ltd1.18%
Shree Cement Limited1.16%
Hindustan Petroleum Corporation Limited0.99%

and 48 smaller holdings (16.2% of the fund).

Method: from each fund's latest monthly portfolio filing, shares only (Indian and foreign equity; bonds, cash and derivatives are left out). Overlap adds up, for every stock both hold, the smaller of the two weights.

Sectors and company size

Tata India Pharma & Healthcare FundICICI Prudential Business Cycle Fund
Large companies26.8%65.3%
Mid companies30.4%14.2%
Small companies40.2%6.5%
Top 10 holdings50.1%45.4%
Largest sectorPharmaceuticals & Biotechnology 64%Banks 22%

Search Growth